News

Healio8h
Ivarmacitinib ‘promising’ for atopic dermatitis not controlled with topical therapies
Oral ivarmacitinib was effective for the treatment of moderate to severe atopic dermatitis in adults and adolescents, ...
Fierce Biotech13h
Leo tames eczema in phase 2b, reporting primary endpoint hit for ex-argenx asset
The phase 2b trial compared four doses of temtokibart to placebo in 262 adults with moderate to severe atopic dermatitis, the ...